Why the study?
Does TAVI improve early outcomes compared to conventional AVR in symptomatic high risk severe aortic stenosis patients?
Does TAVI improve early outcomes compared to conventional AVR in symptomatic high risk severe aortic stenosis patients?
TAVI and conventional AVR showed similar early mortality and periprocedural morbidity in high-risk severe aortic stenosis patients, though TAVI was associated with more vascular complications and paravalvular leakage.
No takes yet. Share an insight, caveat, or question.
Similar early outcomes in this small observational cohort should not change practice; leaves open need for randomized trials in high-risk aortic stenosis.
Yu et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: